
Outpace Bio
Developer of cell therapies designed to improve the safety and efficacy of gene therapies. The company's versatile platform combines the design of biological functions with cellular control modalities...
Valuation
$220M
Latest known
Share Price
N/A
Total Raised
$199M
Last Round
N/A